Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$500M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$470M |
| 3 |
Fortis
FTS
|
+$409M |
| 4 |
AABA
Altaba Inc
AABA
|
+$378M |
| 5 |
Booking.com
BKNG
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.9B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$828M |
| 3 |
Tesla
TSLA
|
+$716M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$585M |
| 5 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$539M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.92% |
| 2 | Financials | 9.63% |
| 3 | Healthcare | 8.27% |
| 4 | Consumer Discretionary | 7.53% |
| 5 | Communication Services | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVLN
2826
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $4.78M | ﹤0.01% |
518,117
+461,831
| +821% | +$4.45M |
|
|
OPPE
2827
WisdomTree European Opportunities Fund
OPPE
$294M
| $4.78M | ﹤0.01% |
162,156
+16,479
| +11% | +$490K |
|
2828
Freshpet
FRPT
$3.51B
| $4.78M | ﹤0.01% |
287,845
+6,380
| +2% | +$87.9K |
|
2829
Interface
TILE
$2.01B
| $4.78M | ﹤0.01% |
242,976
-20,074
| -8% | -$394K |
|
2830
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $4.77M | ﹤0.01% |
140,002
+34,065
| +32% | +$1.14M |
|
|
IMVP
2831
Invesco India ETF
IMVP
$115M
| $4.77M | ﹤0.01% |
209,350
+15,686
| +8% | +$362K |
|
2832
The RMR Group
RMR
$324M
| $4.77M | ﹤0.01% |
98,082
-34,070
| -26% | -$1.72M |
|
2833
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.06B
| $4.76M | ﹤0.01% |
156,234
+6,432
| +4% | +$192K |
|
2834
Ceco Environmental
CECO
$4.04B
| $4.76M | ﹤0.01% |
518,798
+66,544
| +15% | +$671K |
|
|
BRS
2835
DELISTED
Bristow Group, Inc.
BRS
| $4.76M | ﹤0.01% |
622,235
-736,708
| -54% | -$8.11M |
|
|
WEB
2836
DELISTED
Web.com Group, Inc.
WEB
| $4.76M | ﹤0.01% |
188,143
+17,605
| +10% | +$373K |
|
|
POLY
2837
DELISTED
Plantronics, Inc.
POLY
| $4.76M | ﹤0.01% |
91,011
-20,554
| -18% | -$1.11M |
|
2838
LGI Homes
LGIH
$1.43B
| $4.76M | ﹤0.01% |
118,367
-5,552
| -4% | -$186K |
|
|
PRA
2839
DELISTED
ProAssurance
PRA
| $4.75M | ﹤0.01% |
78,198
+24,113
| +45% | +$1.45M |
|
2840
Vanguard International Dividend Appreciation ETF
VIGI
$9.18B
| $4.75M | ﹤0.01% |
76,983
+72,702
| +1,698% | +$4.41M |
|
|
LNW
2841
DELISTED
Light & Wonder
LNW
| $4.74M | ﹤0.01% |
181,731
-95,537
| -34% | -$2.27M |
|
2842
Barings BDC
BBDC
$882M
| $4.74M | ﹤0.01% |
269,104
-64,222
| -19% | -$1.17M |
|
|
RVNC
2843
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.73M | ﹤0.01% |
179,091
+25,421
| +17% | +$567K |
|
|
EXK
2844
Endeavour Silver
EXK
$2.65B
| $4.71M | ﹤0.01% |
1,545,824
+1,259,885
| +441% | +$3.89M |
|
2845
Cable One
CABO
$254M
| $4.71M | ﹤0.01% |
6,627
-8,457
| -56% | -$5.8M |
|
|
VRTSP
2846
DELISTED
Virtus Investment Partners, Inc. 7.25% Series D Mandatory Convertible Preferred Stock
VRTSP
| $4.71M | ﹤0.01% |
46,800
-9,632
| -17% | -$940K |
|
|
FMSA
2847
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $4.71M | ﹤0.01% |
1,206,639
+475,071
| +65% | +$2.46M |
|
2848
GoPro
GPRO
$125M
| $4.7M | ﹤0.01% |
578,521
-101,918
| -15% | -$862K |
|
|
DPLO
2849
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.69M | ﹤0.01% |
317,115
+164,523
| +108% | +$2.74M |
|
2850
VanEck Pharmaceutical ETF
PPH
$927M
| $4.69M | ﹤0.01% |
79,383
-11,348
| -13% | -$642K |
|
Similar funds
Morgan Stanley's Q2 2017 Portfolio in Review
As of Q2 2017, Morgan Stanley held 6,874 positions worth $331B, up 1.7% from $325B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q2 2017 filing shows 204 new, 2,959 increased, 3,018 reduced and 165 closed positions. Its largest new stake was Altaba Inc: 6,949,032 shares worth $379M. The largest sale was iShares Russell 2000 ETF, an estimated $1.9B.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2017 buy was Altaba Inc: 6,949,032 shares worth $379M.
- Morgan Stanley added most to Starbucks in Q2 2017, an estimated $500M increase.
- Morgan Stanley's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.9B.
- Morgan Stanley fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $539M.
- Morgan Stanley's ten largest holdings make up 12% of its $331B portfolio in Q2 2017.
- Morgan Stanley opened 204 new positions and closed 165 in Q2 2017.
- Morgan Stanley's portfolio value rose 1.7% quarter-over-quarter to $331B.
Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.